Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood

Yusuke Tanigawara, Tomoko Kita, Maki Hirono, Toshiyuki Sakaeda, Fusao Komada, Katsuhiko Okumura

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Genotyping of polymorphic drug metabolizing enzymes may be useful to estimate the blood concentration, efficacy, and toxicity of drugs before administration. Blood samples are most generally used for genotyping; however, sampling is invasive and complicated by handling and transport. Therefore, the authors developed genotyping methods using nonblood specimens, and then each genotype was compared with that from blood. Healthy Japanese volunteers provided hairs (n = 50), buccal cell swabs (n = 50), and fingernails (n = 30) for N-acetyltransferase 2 and CYP2C19 genotyping. Recovery of genomic DNA from each nonblood specimen was lower than that from 0.5 mL blood. Using a modification of the DNA extraction and polymerase chain reaction amplification method, genotypes were diagnosed without failure, even for those with very low levels of DNA. Both genotypes from these specimens completely matched the genotypes from the blood of the same subject. These nonblood specimens can be convenient, accessible, and economical alternatives to blood as a source of DNA for genotyping.

Original languageEnglish
Pages (from-to)341-346
Number of pages6
JournalTherapeutic Drug Monitoring
Volume23
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Acetyltransferases
Cheek
Nails
Hair
Blood
Genotype
DNA
Polymerase chain reaction
DNA-Directed DNA Polymerase
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Amplification
Toxicity
Cytochrome P-450 CYP2C19
Healthy Volunteers
Sampling
Recovery
Polymerase Chain Reaction
Enzymes

Keywords

  • Cytochrome P450 2C19
  • Genotyping
  • N-acetyltransferase 2
  • Nonblood specimens
  • Polymerase chain reaction-restriction fragment length polymorphism

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis
  • Pharmacology
  • Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology (medical)
  • Public Health, Environmental and Occupational Health

Cite this

Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood. / Tanigawara, Yusuke; Kita, Tomoko; Hirono, Maki; Sakaeda, Toshiyuki; Komada, Fusao; Okumura, Katsuhiko.

In: Therapeutic Drug Monitoring, Vol. 23, No. 4, 2001, p. 341-346.

Research output: Contribution to journalArticle

Tanigawara, Yusuke ; Kita, Tomoko ; Hirono, Maki ; Sakaeda, Toshiyuki ; Komada, Fusao ; Okumura, Katsuhiko. / Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood. In: Therapeutic Drug Monitoring. 2001 ; Vol. 23, No. 4. pp. 341-346.
@article{e2a680a381934aec924715fb3ff9d778,
title = "Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood",
abstract = "Genotyping of polymorphic drug metabolizing enzymes may be useful to estimate the blood concentration, efficacy, and toxicity of drugs before administration. Blood samples are most generally used for genotyping; however, sampling is invasive and complicated by handling and transport. Therefore, the authors developed genotyping methods using nonblood specimens, and then each genotype was compared with that from blood. Healthy Japanese volunteers provided hairs (n = 50), buccal cell swabs (n = 50), and fingernails (n = 30) for N-acetyltransferase 2 and CYP2C19 genotyping. Recovery of genomic DNA from each nonblood specimen was lower than that from 0.5 mL blood. Using a modification of the DNA extraction and polymerase chain reaction amplification method, genotypes were diagnosed without failure, even for those with very low levels of DNA. Both genotypes from these specimens completely matched the genotypes from the blood of the same subject. These nonblood specimens can be convenient, accessible, and economical alternatives to blood as a source of DNA for genotyping.",
keywords = "Cytochrome P450 2C19, Genotyping, N-acetyltransferase 2, Nonblood specimens, Polymerase chain reaction-restriction fragment length polymorphism",
author = "Yusuke Tanigawara and Tomoko Kita and Maki Hirono and Toshiyuki Sakaeda and Fusao Komada and Katsuhiko Okumura",
year = "2001",
doi = "10.1097/00007691-200108000-00004",
language = "English",
volume = "23",
pages = "341--346",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood

AU - Tanigawara, Yusuke

AU - Kita, Tomoko

AU - Hirono, Maki

AU - Sakaeda, Toshiyuki

AU - Komada, Fusao

AU - Okumura, Katsuhiko

PY - 2001

Y1 - 2001

N2 - Genotyping of polymorphic drug metabolizing enzymes may be useful to estimate the blood concentration, efficacy, and toxicity of drugs before administration. Blood samples are most generally used for genotyping; however, sampling is invasive and complicated by handling and transport. Therefore, the authors developed genotyping methods using nonblood specimens, and then each genotype was compared with that from blood. Healthy Japanese volunteers provided hairs (n = 50), buccal cell swabs (n = 50), and fingernails (n = 30) for N-acetyltransferase 2 and CYP2C19 genotyping. Recovery of genomic DNA from each nonblood specimen was lower than that from 0.5 mL blood. Using a modification of the DNA extraction and polymerase chain reaction amplification method, genotypes were diagnosed without failure, even for those with very low levels of DNA. Both genotypes from these specimens completely matched the genotypes from the blood of the same subject. These nonblood specimens can be convenient, accessible, and economical alternatives to blood as a source of DNA for genotyping.

AB - Genotyping of polymorphic drug metabolizing enzymes may be useful to estimate the blood concentration, efficacy, and toxicity of drugs before administration. Blood samples are most generally used for genotyping; however, sampling is invasive and complicated by handling and transport. Therefore, the authors developed genotyping methods using nonblood specimens, and then each genotype was compared with that from blood. Healthy Japanese volunteers provided hairs (n = 50), buccal cell swabs (n = 50), and fingernails (n = 30) for N-acetyltransferase 2 and CYP2C19 genotyping. Recovery of genomic DNA from each nonblood specimen was lower than that from 0.5 mL blood. Using a modification of the DNA extraction and polymerase chain reaction amplification method, genotypes were diagnosed without failure, even for those with very low levels of DNA. Both genotypes from these specimens completely matched the genotypes from the blood of the same subject. These nonblood specimens can be convenient, accessible, and economical alternatives to blood as a source of DNA for genotyping.

KW - Cytochrome P450 2C19

KW - Genotyping

KW - N-acetyltransferase 2

KW - Nonblood specimens

KW - Polymerase chain reaction-restriction fragment length polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0034896764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034896764&partnerID=8YFLogxK

U2 - 10.1097/00007691-200108000-00004

DO - 10.1097/00007691-200108000-00004

M3 - Article

VL - 23

SP - 341

EP - 346

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 4

ER -